Maternal interleukin (IL) 10 deficiency elevates susceptibility to fetal loss induced by the model Toll-like receptor agonist lipopolysaccharide, but the mechanisms are not well elucidated. Here, we show that Il10 null mutant (Il10 À/À ) mice exhibit altered local T cell responses in pregnancy, exhibiting pronounced hyperplasia in para-aortic lymph nodes draining the uterus with .6-fold increased CD4 + and CD8 + T cells compared with wild-type controls. Among these CD4
INTRODUCTION
Inheritance by the conceptus of maternal and paternal transplantation antigens results in a semiallogeneic challenge to the mother. Substantial adaptations in the maternal immune system are required to tolerate the fetus and suppress deleterious inflammatory responses that cause gestational disorders and fetal demise. Secretion of immune-regulatory cytokines and hormones by placental trophoblasts and uterine cells [1] [2] [3] constrain inflammation and limit type 1 immunity, particularly in the gestational tissues and local lymph nodes (LNs). Prominent among these cytokines is interleukin (IL) 10 [1, 4] , which stimulates and reinforces modifications to the innate and adaptive immune system, including induction of regulatory phenotypes in the dendritic cell (DC), macrophage, and T lymphocyte compartments [5] [6] [7] . Experiments in Il10 null mutant (Il10 À/À ) mice demonstrate that in the absence of maternal IL10, neither allogeneic nor syngeneic pregnancies are compromised [8] [9] [10] . However, pregnant Il10 À/À mice are highly vulnerable to inflammatory challenge, with administration of low-dose lipopolysaccharide (LPS) or other Toll-like receptor (TLR) ligands causing elevated rates of fetal resorption (miscarriage) [11, 12] or preterm delivery [13, 14] , depending on gestational timing of the insult.
The mechanisms through which IL10 controls inflammatory mediators have not been defined, although uterine natural killer (uNK) cells and tumor necrosis factor (TNF) appear to be involved in promoting fetal loss when pregnant Il10 À/À mice are challenged [11] . We postulate that in the absence of IL10, anti-inflammatory mechanisms protecting the fetus are compromised. One of the key leukocyte populations likely to be affected by absence of IL10 are T regulatory (Treg) cells, a subset of anti-inflammatory and immune suppressive CD4 þ T lymphocytes defined by their expression of the transcription factor fork-head box P3 (Foxp3) [15, 16] . The critical role of Treg cells in limiting inflammation and mediating immune tolerance is demonstrated in Foxp3 null mutant mice (Scurfy mice) that develop a lethal multiorgan lymphoproliferative disorder [17] . IL10 is implicated in the generation of Treg cells and is prominent in aspects of their suppressive function [7, 18] , including in pregnancy, where neutralizing IL10 abrogates the protective effects of Treg cells in a murine abortion model [19] . IL10 also influences macrophages and DCs, which have important roles in sustaining pregnancy independently of T cells [20] as well as through specific antigen-presenting and immune-regulatory functions, including control of the generation of induced Treg cells from naïve T lymphocyte precursors [7] .
During murine pregnancy, Treg cells are elevated in the gestational tissues and systemic circulation by approximately 50% in midgestation [10, 21] , and similar changes are evident in pregnant women [22, 23] . Experiments in Treg cell-depleted mice [24, 25] and abortion-prone mice [26] show these cells are essential for establishing allogeneic pregnancy. Their immune regulatory actions are most crucial around the time of embryo implantation, when their abundance is a limiting factor in implantation and placental development [27] . Experiments using tetramers demonstrate the majority of the maternal Treg cells that expand in pregnancy are fetal antigenspecific [10] , and dependence on the CNS1 regulatory region in the Foxp3 gene confirms this is at least partly the result of extrathymic generation of inducible (peripheral) Treg cells responding to fetal alloantigen [28] after initial priming in response to paternal seminal fluid at conception [29] . Treg cells have recently been shown to protect the fetus from preterm delivery induced by the TLR4 ligand bacterial LPS [30] and from fetal loss induced by the TLR9 ligand DNA motif CpG [31] . Although Treg cells can develop and execute at least some protolerance functions independently of IL10 [10, 32, 33] , to our knowledge the effect of IL10 deficiency on Treg cell populations in pregnancy has not been investigated.
In the present study, we demonstrate significant alterations in the maternal Treg cell response to allogeneic pregnancy in female mice with genetic IL10 deficiency. We report substantial lymphocyte hyperplasia within the uterine-draining para-aortic LNs, accompanied by a substantial increase in the total number and relative proportion of CD4
Treg cells, that is most pronounced in midgestation. Experiments to define the mechanisms underlying these changes in the T cell compartment reveal altered phenotypes in DCs and macrophages and demonstrate that in pregnancy, Treg cells generated in local para-aortic LNs exhibit diminished stability linked with reduced Foxp3 protein expression and altered transcription of several genes associated with regulatory function compared with their wild-type counterparts.
MATERIALS AND METHODS

Mice and Surgical Treatments
BALB/c mice were purchased from the University of Adelaide Central Animal Facility. C57BL/6 (B6; Il10 þ/þ ), and Il10 À/À mutant mice back-crossed through the same B6 colony were bred in-house under specific pathogen-free conditions at the University of Adelaide Medical School Animal House under a 12L:12D photoperiod and were administered food and water ad libitum. Il10 À/À mutant mice were generated by targeted mutation of the Il10 gene in 129/Ola embryonic stem cells, propagated on a B6 background [34] . Null mutant status was confirmed in Il10 À/À mice by PCR of DNA extracted from blood or tail tissue of adult mice. PCR primers diagnostic for the Il10 null mutation and the neomycin insertion cassette were as previously reported [34] . Experiments were performed in accordance with the Australian Code of Practice for the Care and Use of Animals for Scientific Purposes, with approval from the University of Adelaide Ethics Committee. Il10 À/À mice received broad-spectrum antibiotics (100 g/kg of oxytetracycline hydrochloride; Oxymav 100; Mavlab) in autoclaved drinking water twice weekly at a concentration of 2 mg/ml to prevent colitis.
Mating was confirmed by the presence of a vaginal plug between 0900 and 1100 h. The morning of confirmation of mating was termed Day Postcoitum (DPC) 0.5. Mated Il10 À/À and Il10 þ/þ females were removed from males, caged in groups of one to three per cage, and killed at different time points over the course of pregnancy to evaluate immune parameters. For analysis of fetal loss rates and late gestation pregnancy parameters, Il10
À/À and Il10 þ/þ females mated with BALB/c males and identified as pregnant with more than 2.0 g of weight gain after DPC 0.5 were administered LPS (Salmonella typhimurium; 0.25 lg in 200 ll PBS i.p.; Sigma) or PBS control at 1100 h on DPC 9.5, then killed by cervical dislocation at between 1000 and 1200 h on DPC 17.5. The intact uterus of each female was removed, and total, viable, and resorbing implantation sites were counted. Each viable fetus was dissected from the amniotic sac and umbilical cord, and fetuses and placentae were weighed.
Flow Cytometry
Para-aortic and inguinal LNs were excised from female mice between 0900 and 1100 h at estrus or at various time points in pregnancy. Single-cell suspensions were prepared by mechanical dispersion between glass microscope slides. Lymphocytes were suspended in 0.1% BSA/PBS with 0.05% sodium azide (pH 7.4; fluorescence-activated cell sorting [FACS] buffer). Aliquots of 10 6 cells were incubated with anti-Fc-cIIR (FcBlock; BD Biosciences) for 5 min at 48C, then incubated with combinations of phycoerythrin (PE) anti-CD4 (L3T4; BD Biosciences), fluorescein isothiocyanate (FITC) anti-CD8 (Ly-2; BD Biosciences), and PE-Cy7 anti-CD25 (PC61; eBioscience) for 30 min at 48C to identify T cell subsets. Following T cell surface staining, cells were fixed and permeabilized using Foxp3 Staining Buffer Set (eBioscience) according to the manufacturer's instructions. Permeabilized cells were incubated with anti-Fc-cIIR for 5 min at 48C and then with APC anti-Foxp3 (FJK-16s; eBioscience) for 30 min at 48C.
To analyze other leukocyte subsets and to phenotype DCs and macrophages, aliquots were incubated with anti-Fc-cIIR antibody plus combinations of APC anti-CD11b (M1/70; eBioscience), AF488 anti-CD11c (N418; eBioscience), PE-Cy7 anti-CD19b (eBio 1D3; eBioscience), PE or biotin anti-F4/80 (BM8; eBioscience), PE anti-CD4 (L3T4; BD Biosciences), biotin anti-major histocompatability class II (MHCII; M5/114.15.2; eBioscience), biotin anti-MHCII, scavenger receptor class A (macrophage scavenger receptor [MSR]; 2F8; AbD Serotec), biotin anti-CD80 (16-10A1; BD Biosciences), and APC anti-CD86 (GL1; BD Biosciences) for 30 min at 48C, followed by PerCp Streptavidin (BD Biosciences). After washing, cells were stained with 4 0 ,6-diamidino-2-phenylindole and were analyzed on a FACSCanto II flow cytometer using FACSDiva software (both from BD Biosciences). For quantification of total cell numbers, CountBright Absolute Counting Beads (Molecular Probes, Invitrogen) were added to aliquots of LN cells to quantify the total number of leukocyte subsets relative to their ratio to CD4 þ or CD19b þ cells. 
T Cell Suppression Assays
CD4 þ CD25 þ cells
Cytokine Stimulation Assays
Single-cell suspensions of para-aortic LN from DPC 9.5 pregnant Il10 þ/þ or Il10 À/À mice mated with BALB/c males were incubated in cRPMI at 7. buffer, cells were analyzed on a FACSCanto flow cytometer using FACSDiva software (both BD Biosciences).
Immunohistochemistry
Sections (thickness, 7 lm) taken from paraffin-embedded whole implantation sites (including fetus, placenta, and decidua) recovered from DPC 9.5 pregnant Il10
À/À mice were dewaxed in xylene before rehydration and antigen retrieval by incubation in citrate buffer (10 mM sodium citrate, pH 6.0) in an autoclave at 1218C and 15 psi for 10 min. Nonspecific antibody binding was blocked by incubation for 1 h at room temperature with 10% normal rabbit serum (Sigma-Aldrich) in PBST (13 PBS and 0.025% Tween-20; Sigma-Aldrich), and endogenous peroxidase activity was blocked in 3% hydrogen peroxide (Sigma-Aldrich) for 10 min. Sections were subsequently incubated with anti-Foxp3 (FJK-16s) primary antibody (1:400 dilution) overnight at 48C, followed by biotinylated rabbit anti-rat (1:400; Dako) for 1 h at room temperature and streptavidin-conjugated horseradish peroxidase (Vectastain ABC Kit; Vector Laboratories) according to the manufacturer's instructions with detection using a diaminobenzidine peroxidase substrate kit (Vector Laboratories). Images were captured using a NanoZoomer 1.0 (Hamamatsu) at a zoom equivalent of a 203 objective lens. Cell density was calculated by counting Foxp3 þ cells in three tissue sections (at least 100 lm apart) from each of two or three implantation sites per mouse and then dividing by the section area, calculated by tracing of the section outline using NDP-view software (Hamamatsu).
RNA Extraction and Microarray Analysis
The RNA was extracted from CD4
þ lymphocytes isolated from para-aortic LNs of DPC 9.5 pregnant Il10 þ/þ or Il10 À/À mice using miRNeasy Mini Kits (Qiagen, Inc.) according to the manufacturer's instructions. The concentration and purity of each RNA sample was determined using an ND-1000 spectrophotometer (NanoDrop Technologies, Inc.). RNA quality was determined using the RNA 6000 Pico Total RNA Kit (Agilent Technologies) before use in microarray experiments. RNA with an RNA integrity number (RIN) greater than seven was used in the present study.
For microarray analysis, RNA was pooled (n ¼ 2-4 mice/pool), resulting in four biological replicates of CD4 þ CD25 þ cells from both Il10 À/À and Il10
mice. Microarray analysis was performed using Affymetrix Mouse Gene 2.0 ST Arrays at the Adelaide Microarray Centre. Total RNA was amplified using the Ovation PicoSL WTA System V2 (Nugen, Inc.) and MinElute Reaction Cleanup Kit (Qiagen, Inc.), according to the manufacturer's instructions, to provide 5 lg of cRNA for each microarray. The microarray data were normalized and analyzed using Partek Genomics Suite (Partek, Inc.). Raw data from the Affymetrix platform (.cel files) were imported and normalized using RMA background correction, Partek's own guanine-cytosine (GC) content correction, and mean probe summarization. A threshold of either a greater than 1.4-fold change (low stringency) or a greater than 2.0-fold change (high stringency) was used to identify differentially expressed genes, with a false-discovery rate of 0.05.
The microarray data discussed in this publication have been deposited in the National Center for Biotechnology Information's Gene Expression Omnibus and are accessible through GEO Series accession no. GSE71494 (www.ncbi. nlm.nih.gov/geo/query/acc.cgi?acc¼GSE71494).
Quantitative RT-PCR
Quantitative RT-PCR (qPCR) was used to confirm microarray data. Total cellular RNA was reverse transcribed from 125 ng of random hexamer primed RNA from each of 8-12 individual Il10 À/À and Il10 þ/þ mice employing a Superscript-III Reverse Transcriptase kit (Invitrogen) following the manufacturer's instructions. Primer pairs specific for published cDNA sequences were designed using Primer Express version 2 software (Applied Biosystems) (Supplemental Table S1 ; all Supplemental Data are available online at www. biolreprod.org). Assay optimization and validation experiments were performed using cDNA from murine para-aortic LN tissue to determine the amplification efficiency of each primer pair. All primers were determined to have a correlation coefficient of greater than 0.95 and an efficiency of between 90% and 110%. PCR primer products were purified from 2% agarose gels and sequenced (Australian Genome Research Facility, Adelaide) to confirm primer specificity.
The qPCR was performed using 1 ng of cDNA, supplemented with 0.1-0.5 lM 5 0 and 3 0 primers (Supplemental Table S1 ) and 13 SYBR Green PCR Master Mix (Applied Biosystems). The negative control included in each reaction contained H 2 O substituted for cDNA. PCR amplification was performed in an ABI Prism 7000 Sequence Detection System (Applied Biosystems) using reaction conditions of 958C for 10 min, then 40 cycles of 958C for 15 sec and 608C for 1 min. The Delta C(t) method was then used to calculate mRNA abundance normalized to Gmpr mRNA expression.
Statistics and Data Analysis
Unless stated otherwise, the effect of maternal genotype was analyzed using unpaired t-test, or one-way ANOVA and Sidak t-test for multiple comparisons, using GraphPad Prism 6 for Windows (GraphPad Software, Inc.) after confirming normality of distribution using the Shapiro-Wilk normality test in SPSS Statistics Version 17.0 (IBM Corporation). Individual data points were excluded as outliers if greater than 2 SD from the mean. Difference in groups were considered significant if P , 0.05. The qPCR data were not normally distributed and were analyzed by a Kruskal-Wallis H-test and the MannWhitney U-test taking into account multiple comparisons. Statistical significance in differences between the groups was concluded when P , 0.05.
RESULTS
Maternal IL10 Deficiency Elevates LPS-Induced Fetal Loss
Previously, we reported that the Il10 null mutation causes elevated fetal loss when pregnant mice carrying syngeneic IL10-deficient fetuses are administered low-dose LPS [12] . To investigate the contribution of maternal IL10 to this increased susceptibility, Il10
À/À and Il10 þ/þ B6 females were mated with Il10 þ/þ BALB/c males to generate allogeneic pregnancies with maternal, but not fetal, IL10 deficiency. On DPC 9.5, pregnant females were administered LPS at a low dose (0.25 lg/mouse) identified previously to induce fetal loss in pregnant Il10 [12] . In mice examined just before term on DPC 17.5, Il10
À/À mice were more severely affected by LPS treatment than control mice, with a lower proportion of Il10 À/À mice carrying viable fetuses at DPC 17.5 (33% in Il10 À/À and 91% in Il10 þ/þ mice, P ¼ 0.019) (Fig. 1A) . Furthermore LPS caused a higher rate of fetal resorption in (Fig. 1B) , resulting in significantly fewer viable fetuses per mated female (Fig. 1C) . No effects of genotype or LPS treatment on fetal weight, placental weight, or fetal weight:placental weight ratio were seen (data not shown). Thus, elevated fetal loss in Il10 À/À mothers can be largely attributed to maternal, as opposed to fetal, IL10 deficiency, implicating a defect in the maternal immune adaptations protecting pregnancy.
IL10 Deficiency Causes LN Hypertrophy at Midgestation
To explore the underlying immune pathways contributing to LPS-induced fetal loss in the absence of maternal IL10, Il10 À/À and Il10 þ/þ females were mated with BALB/c males and leukocyte populations in para-aortic LNs draining the uterus were examined at various time points in gestation. Substantially greater hypertrophy of the para-aortic LNs was observed in pregnant Il10 À/À mice at DPC 9.5 in midgestation, when Il10 À/À mice consistently showed a greater than 10-fold increase in para-aortic LN mass compared to controls (Fig. 2,  A and B) . No obvious difference in LN size attributable to genotype was seen in para-aortic LN in unmated mice or at DPC 6.5 or 13.5 (data not shown).
Flow cytometry was utilized to determine the composition and relative abundance of leukocyte subpopulations in paraaortic LNs at DPC 9.5. Subcutaneous inguinal LNs, which do not drain the uterus [35] , were also analyzed for comparison. T cells accounted for the greatest increase in LN hypercellularity, with the absolute number of CD4 þ cells increased 6.7-fold and that of CD8 þ cells increased 8.3-fold, whereas CD19b þ B cells were increased 3.4-fold and CD11c þ DCs increased 3.6-fold in para-aortic LNs from Il10 (Fig. 2C) . The absolute number of macrophages expressing CD11b or F4/80 was comparable regardless of genotype (Fig. 2C ). In the inguinal LNs, where no overt LN hypertrophy was evident, the only significant change in Il10
þ , and CD8 þ cells were all unchanged (Fig. 2D) .
Treg Cell Pool Is Expanded in Pregnant IL10-Deficient Mice
To determine whether IL10 deficiency affects Treg cell populations in pregnant Il10
À/À mice, we initially assessed Foxp3 expression by CD4 þ cells in para-aortic and inguinal LNs. At DPC 9.5, when LN hypertrophy was most evident, the percentage of CD4 þ cells expressing Foxp3 was increased from 13% to 21% in Il10 À/À mice compared with Il10 þ/þ mice (P , 0.001) (Fig. 3A) . With the increase in total CD4 þ cells, this resulted in an 11.3-fold increase in the absolute number of CD4 þ Foxp3 þ cells (P , 0.001) (Fig. 3B ) in Il10 À/À mice compared with Il10 þ/þ mice. Within the inguinal LN, the proportion of CD4 þ cells expressing Foxp3 at DPC 9.5 was increased 1.4-fold (P , 0.001) (Fig. 3C) , with a 1.8-fold increase in total CD4
þ Foxp3 þ cells (P , 0.05) (Fig. 3D) . A relative increase in the proportion of CD4 þ cells expressing Foxp3 was also seen at other time points in pregnancy and also in virgin mice, albeit to a lesser extent than at DPC 9.5 ( Fig. 3A) , resulting in 2.1-to 4.2-fold increases in total CD4
þ Foxp3 þ cells at these other times (Fig. 3B) . Within the inguinal LNs, CD4 þ cells were also more likely to express Foxp3 throughout pregnancy and in virgin mice (P , 0.001) (Fig. 3C) , causing a modest, but consistent, 1.3-to 1.9-fold increase in CD4
þ Foxp3 þ cells attributable to IL10 deficiency (P , 0.001) (Fig. 3D) .
As well as LNs draining the uterus, Treg cells are present in the maternal and fetal compartments of gestational tissues [21] . Immunohistochemistry was utilized to quantify Foxp3 þ cells in sections of maternal uterine decidua from embryo implantation sites on DPC 9.5. Among the sparse populations of Treg cells seen in decidual tissue, no overt difference was evident in pregnant Il10
À/À compared with Il10 þ/þ females (Supplemental Fig. S1 ). 
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positive for expression of MHCII, MSR1, and CD80 (Fig. 4,  A-C) . The proportions of CD11c þ DCs classified as CD80 high or MHCII high were increased, and the CD80 mean fluorescence intensity was higher in Il10 À/À mice. No changes in CD86 expression were attributable to IL10 deficiency (data not shown).
In F4/80 þ macrophages, the proportion expressing CD80 was significantly higher, the proportion classified as CD80 high was higher, and the mean fluorescent intensity of CD80 in F4/ 80 þ macrophages was higher in Il10 À/À mice compared to controls (Fig. 4D) , although changes in MHCII, MSR1, and CD86 were not evident (data not shown). (Fig. 5, A and B) .
IL10 Deficiency Reduces
À/À and Il10 þ/þ mice showed comparable capacity to suppress proliferation of responder CD4 þ CD25 À T cells stimulated by BALB/c splenocytes (Fig.  5C) . Similarly, no reduction was observed in suppressive capability of CD4 þ CD25 À cells from para-aortic LNs of DPC 9.5 pregnant mice (Fig. 5D ).
IL10 Deficiency Alters Gene Expression Profile in Treg Cells
The reduced Foxp3 expression raised the question of whether Treg cells have an altered phenotype in pregnant Il10 À/À mice. To examine this, we performed a microarray experiment using the Affymetrix arrays on CD4 þ CD25 þ T cells isolated by magnetic cell sorting from para-aortic LNs of Il10 À/À and Il10 þ/þ mice on DPC 9.5. Four biological replicates of CD4 þ CD25 þ T cell RNA (each pooled from two or three different mice) from each genotype were reverse transcribed into cDNA and hybridized to Affymetrix Mouse Gene 2.0 ST Arrays. Principal component analysis showed clustering of cDNAs according to genotype (Supplemental Fig.  S2A ). A total of 52 probe sets were classified as highly differentially expressed with high-stringency criteria (foldchange . 2.0, P , 0.05) between genotypes, with 45 genes upregulated and 7 genes downregulated (Supplemental Fig.  S2B ). Of the genes upregulated in T cells from Il10 À/À mice, seven have potential relevance to Treg cell function, identified by Ingenuity Pathway Analysis and literature searches as 
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linked with cytokine-cytokine receptor interactions (Il10; upregulated 2.1-fold), maintenance of Treg cell function (Ctse, Lilrb4, and Slpi; upregulated 7.2-, 2.1-, and 2.7-fold, respectively), and loss of Treg cell function (Cd24a, Ighm, and Igj; upregulated 2.0-, 10.1-, and 3.1-fold, respectively) ( Table 1) . Using a low-stringency analysis (fold-change . 1.4, P , 0.1), a total of 299 genes were classified as moderately differentially regulated by IL10 deficiency, including 247 that were upregulated and 52 that were downregulated in Il10 À/À compared to Il10 þ/þ Treg cells. Of these, a further 40 genes were identified as associated with cytokine signaling or Treg cell stability and function, with a total of 42 upregulated and 5 downregulated in Il10 Table S2 ).
Several genes of interest were independently quantified by qPCR in CD4 þ CD25 þ T cells from para-aortic LN of pregnant Il10 þ/þ and Il10 À/À mice on DPC 9.5. In the absence of IL10, increases were detected in expression of Ctse encoding the intracellular proteinase cathepsin E (155-fold, P , 0.0001) (Fig. 6A) , Ctla2a encoding the cytotoxic T lymphocyteassociated protein 2 complex CTLA2 (4.4-fold, P , 0.01) (Fig.  6B) , Il1r1 encoding the IL1 receptor type 1 (10.4-fold, P , 0.05) (Fig. 6D) , and Ifng encoding the Th1 cytokine IFNG (6.3-fold, P , 0.05) (Fig. 6E) . A trend to increased expression was seen in Il12rb2 encoding the IL12 receptor beta 2 subunit (8.3-fold, P ¼ 0.076) (Fig. 6F) . No consistent change was seen in expression of other genes identified as moderately differentially regulated in the microarray, including Il17a (Fig. 6C) , Ccr6, Il17rb, and Il10ra (data not shown).
IL10 Deficiency Reduces the Stability of Foxp3 Expression in Stimulated Treg Cells
To further explore the effect of IL10 deficiency on the functional phenotype of Treg cells, experiments were undertaken to investigate the stability of Foxp3 expression after strong polyclonal stimulation of T cells recovered from Il10 PRINS ET AL.
and inguinal LNs, respectively, but only by 38% and 34%, respectively, in Il10 þ/þ mice, compared with unstimulated cells from the same genotype (both P , 0.01) (Fig. 7, A and B) . Intracellular cytokine staining (Supplemental Fig. S3) showed that the increased loss of Foxp3 was accompanied by a lower proportion of stimulated CD4 þ T cells from the para-aortic LNs of Il10 À/À mice expressing IL4 and IL9 (both P , 0.05) (Fig. 7C) , with a trend to higher IL17 (P ¼ 0.087), compared to þ Foxp3 þ cells in the para-aortic and inguinal LN populations, respectively, (both P , 0.05) (Fig. 7, E and F) . PRINS ET AL.
DISCUSSION
Appropriate control of maternal inflammation is essential for optimal fetal growth and on-time birth. Treg cells are paramount among the immune-regulatory leukocytes operating to suppress inflammation and promote tolerance at the fetalmaternal interface in pregnant females [24, 36] . Currently, a lack of understanding of the maternal and fetal factors that control the generation and suppressive function of Treg cells is a limitation in our capacity to tackle human gestational disorders, including preeclampsia and preterm birth. These conditions result from excessive maternal inflammation and are associated with disturbances in Treg cell populations [23, 36] . In the present study, we demonstrate that despite hyperproliferation well beyond the expansion seen in normal pregnancy, the Treg cells generated in uterine-draining LNs of pregnant Il10 À/À mice display reduced Foxp3 expression, altered expression of Ctse and other genes linked with Treg function, and functional features indicating decreased stability. These altered Treg cell characteristics are likely to contribute, together with the increased CD4 þ and CD8 þ T effector cells and the proinflammatory shift in DC and macrophage phenotypes, to the elevated susceptibility of Il10 À/À mice to inflammatory challenge and fetal loss [11] [12] [13] .
Altered T cell immunity in IL10-deficient mice appears not to affect tolerance of fetal alloantigens, because steady-state pregnancy progresses normally irrespective of the alloantigenic À/À mice (hatched bars, n ¼ 9). The effect of genotype was evaluated using Mann-Whitney U-test (*P , 0.05, **P , 0.01, ****P , 0.0001, # P , 0.1).
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status of the fetus [8] . The functional requirement for IL10 becomes apparent when pregnant Il10 À/À mice are administered low-dose LPS to induce a systemic inflammatory response, revealing a key role for IL10 in protecting the fetal-placental tissues from uncontrolled inflammatory cytokines and natural killer cell cytotoxicity causing fetal death and/or preterm labor [11] [12] [13] . Thus, it seems that a major function of the copious IL10 produced by leukocytes, placental trophoblasts, and other cell lineages in gestational tissues [4] is to buffer pregnancy in the event of an inflammatory insult.
Here, we show that IL10 in the maternal compartment, as opposed to the fetal or placental tissues, is most crucial for protecting pregnancy. This implies a pivotal role for endogenous IL10 in supporting anti-inflammatory and protolerance mechanisms in the mother. Given the key actions of IL10 in Treg cell biology [37, 38] and the importance of induced Treg cells in pregnancy [28] , we investigated CD4 þ Foxp3 þ Treg cells and found that when maternal IL10 synthesis is disrupted, the generation of Treg cells is disturbed. A striking LN hyperplasia was evident in Il10 À/À mice compared with wild- 
IL17
þ to CD4 þ Foxp3 þ cells from para-aortic LNs (E) and inguinal LNs (F) after stimulation was calculated. Data are the mean 6 SEM from Il10 þ/þ mice (open bars, n ¼ 7) and Il10 À/À mice (hatched bars, n ¼ 6). The effect of genotype and stimulation was evaluated using ANOVA and unpaired t-test (A and B) ; the effect of genotype was evaluated using Sidak t-test (C and D) or unpaired t-test (E and F) (*P , 0.05, **P , 0.01, ***P , 0.001,
PRINS ET AL. type controls. This was most pronounced at midgestation and was mainly accounted for by CD4 þ and CD8 þ T cells. Compared to T effector cells, Treg cells were disproportionately enriched more than 11-fold compared to wild-type controls at the same pregnancy phase. Treg cells were more dramatically increased in the para-aortic LNs draining the uterus than in the inguinal LNs or at other distal sites (not shown). A 2-to 4-fold increase was also seen in the para-aortic LNs of Il10 À/À mice before pregnancy and at earlier and later times of gestation, whereas a smaller, 50%-100% increase in the inguinal LNs is in line with previous observations of broadly similar T cell populations in Il10 À/À mice [34] . Para-aortic LN hypertrophy was most pronounced in Il10 À/À mice in the midgestation phase, peaking around DPC 9.5. This pattern of response fits with the kinetics demonstrated for maternal exposure to conceptus histocompatibility antigens [39, 40] . The timing coincides with structural changes in the developing placenta that allow maternal blood flow into the placental labyrinth compartment to commence between DPC 9.5 and DPC 10.5 [41] , such that intimate contact between maternal immune cells and placental trophoblast antigens escalates at this time.
It is important to consider that in the present study, because fetuses were heterozygous for the Il10 gene, the maternal compartment is not entirely IL10 deficient. IL10 derived from the fetus and placenta can enter the maternal system, and it would be highest through the second half of gestation, when maternal blood enters the placental labyrinth. Paracrine effects of fetal IL10 on maternal immune cells could reasonably explain the resolution of LN hypertrophy by DPC 12.5. This may also explain why the fetal growth impairment seen previously after midgestation LPS administration when IL10 is absent from both maternal and fetal tissues [12] was not recapitulated in the present study.
The expanded Treg cell pool in midgestation pregnant IL10-deficient mice is accompanied by, and may be the consequence of, an altered phenotype in antigen-presenting cells. We found elevated expression of activation markers MHCII and CD80 in DCs, plus elevated CD80 in macrophages, within para-aortic LNs of pregnant Il10 À/À mice. DCs matured in the absence of IL10 have elevated ability to process and present antigens and secrete proinflammatory cytokines [6, 42, 43] . Our results are consistent with those of previous studies in Il10 À/À mice, where elevated DC expression of MHCII, costimulatory molecules, and cytokines IFNG, IL12, and IL17 were reported in other tissues [44, 45] . This phenotype is thought to contribute to skewing the T cell response toward Th1 and Th17 cell prominence, manifesting as exaggerated hypersensitivity [46] , chronic enterocolitis [34] , and elevated cell-mediated immunity to several pathogens [47] .
Lymph node hyperplasia coincides with a phase of accumulation of CD11c þ DCs in the uterus, which characteristically exhibit a tolerogenic phenotype with a dominance of IL10 over IL12 production [48] . The 3.6-fold increase in DCs in the para-aortic LN of Il10 À/À mice could reflect increased migration of antigen-presenting cells from the uterus, as reported for Langerhans cells in the skin of Il10 À/À mice [49] , in response to increased TNF production in gestational tissues when IL10 is deficient [11, 12] . The combined effect of enhanced DC migration and greater antigen-presenting activity would explain the global expansion in T cell populations. Cross-regulation between Treg cells and DCs presumably amplifies skewing toward more proinflammatory phenotypes in both compartments, because Treg cell-derived factors are required to maintain a tolerogenic DC phenotype [6, 50] .
Previously, uNK cells have been shown to be differentially activated in pregnant Il10 À/À mice [11] , to be differentially activated in Il10 À/À mice after low-dose LPS administration, and to be instrumental in the effector pathway linking IL10 deficiency with fetal loss [11] . The present study supports the interpretation of upstream effects of Treg cells in suppressing natural killer cell activation, consistent with other data showing uNK cell capacity to respond to Treg cell regulation [51, 52] .
The mechanism driving selectively greater expansion of Treg cells compared to the residual T cell pool with IL10 deficiency in pregnancy is not known but might reflect a compensatory mechanism to offset reduced suppressive function. IL10 is clearly not essential for the generation of either natural or adaptive Foxp3 þ Treg cells [7] . Selective skewing away from the Treg compartment might have been expected in Il10 À/À mice, and it is reported in respiratory tract infection, where Treg cells are diminished whereas Th1 and Th17 cells are selectively expanded [53] . Contrary to expectations, the pregnancy-associated bias toward inducible Treg cell generation is maintained in the absence of IL10, potentially due to elevated transforming growth factor beta (TGFB) [54] and the range of other overlapping immunedeviating mechanisms operating in pregnancy [2] . The present study did not seek to formally compare effects of IL10 on Treg cells in nonpregnant mice or in sites beyond the uterinedraining LNs, but our time-course experiments and comparisons between para-aortic and inguinal LNs imply there may be subtle effects of IL10 deficiency with elevated numbers of Treg cells in nonpregnant estrous mice and in inguinal LNs not draining the uterus. IL10-mediated mechanisms that ultimately constrain Treg cell generation may not be confined to pregnancy; a recent study reports elevated Foxp3 þ Treg cells in the liver of IL10-deficient mice in the late stages of Brucella abortus infection [47] . However, further investigation will be required to determine whether inducible or thymic Treg cells exhibit differences in gene expression or function in IL10-deficient mice in other physiological or pathophysiological settings.
Despite the lack of effect on suppressive function in vitro, the present study indicates that stability of Treg cells in pregnant mice was altered by IL10 deficiency. Notably, reduced Foxp3 expression was evident in Treg cells from pregnant Il10 À/À mice, and a greater disposition to Foxp3 loss occurred when IL10-deficient T cells were activated in vitro. Differentiation of the Treg lineage is not terminal, and Treg cells can be induced to reprogram into Th1 or Th17 cells when exposed to inflammatory cytokines, such as IL6, IFNG, or IL1 [55] . The extent to which Treg cells remain stably committed or exhibit plasticity is determined by methylation of the Foxp3 gene plus the activity of several additional transcription factors and posttranscriptional regulators [56] . The precise mechanism by which IL10 deficiency alters stability is not clear, but IL10 interacts with transcription factors, such as GATA3, that control Foxp3 expression [57] . We did not find reduced Foxp3 mRNA levels in Treg cells from Il10 À/À mice, consistent with emerging pathways for posttranscriptional control of Foxp3 expression in Treg cells [58] .
Affymetrix microarray analysis indicated an altered pattern of gene expression in Treg cells in pregnant Il10
À/À mice. This may be a compensatory response to lack of autocrine IL10 signaling. Production of IL10 by Treg cells is one of the central pathways mediating suppressive function, and IL10 deficiency constrains Treg cell function to differing extents depending on the tissue [38, 59] . This fits with an emerging picture of unique, nonredundant, and specialized roles for individual suppressive mediators in Treg cells that are exploited in different IL10 REGULATES TREG CELLS IN PREGNANCY physiological and pathophysiological settings [38] . Cell lineage-restricted Il10 null mutation in Foxp3 þ cells shows a dominant, nonredundant role for Treg cell-derived IL10 in maintaining immune homeostasis at environmental surfaces, including the colon, lung, and skin [38] . T cell-specific blockade of IL10 signaling shows that IL10 production from CD4 þ Foxp3 þ Treg cells is important for Treg cell suppression of Th17 and Th1 cells [60] .
Whether altered Treg cell function in pregnancy is due to absence of IL10 from Treg cells or from other cell lineages, such as DCs that control Treg cell production, remains to be determined. In mice with a null mutation in Foxp3 specific to the T cell lineage, the progression of allogeneic pregnancy under steady-state conditions is not impaired, despite changes to pathogen defense [10] . Neither is Treg cell-derived IL10 required for homeostasis of the nonpregnant uterine mucosa, and a moderate delay in resolution of the inflammatory response to seminal fluid at mating does not compromise fertility [8] . Suppressive pathways independent of IL10 exist in Treg cells, and presumably, these account for normal tolerance of seminal fluid and progression of allogeneic pregnancy in Il10 À/À mice. These include secretion of immune suppressive cytokines other than IL10, such as TGFB and IL35; cell-cell contact-dependent mechanisms; contact-independent mechanisms, such as IL2 and ATP depletion; and stimulation of tryptophan catabolism [18, 61] .
Among the most strongly upregulated genes in Treg cells from Il10 À/À mice was Ctse, encoding the endolysosomal aspartic proteinase, cathepsin E. Cathepsin E is implicated as a key factor contributing to adaptive Treg suppressive mechanisms that are independent of IL10. Elevated cathepsin E was previously reported in Treg cells engineered for deficiency in both IL10 and IL35, where it promotes TNF-related apoptosisinducing ligand (TRAIL)-mediated suppression, to compensate for loss of IL10 and IL35 [33] . Cathepsin E is also associated with increased turnover of IL1B and IL18 through degradation of the protein sequestering molecule a 2 -macroglobulin [62] . Ctse is induced in inflammation [63] in response to cytokines, including IL17 [64] and IFNG [65] . A previous study found elevated Ctse expression in Il10 À/À mice after ozone-induced inflammation in the lung [66] .
Other differentially regulated genes were detected in Treg cells from Il10 À/À mice, with upregulated Ifng and a trend to elevated Il17 expression. This shift in disposition to Th1 and Th17 gene expression may contribute to the instability of Il10 À/À Treg cells we observed after proinflammatory stimulation. Genes encoding cytokine receptors IL1r1 and IL12rb2 were elevated, as was the T cell marker CTLA2. IL12rb2 is required for TGFB-dependent stimulation of Treg cell development, and signaling via this receptor is thought to regulate the number and functional maturity of Treg cells [67] .
In summary, we have demonstrated that in pregnancy, maternal IL10 is a key determinant of protection from inflammatory challenge, acting to tailor both the size and the stability of the induced Treg cell pool. These changes likely are reinforced by interactions with DCs and macrophages that exhibit a more immunogenic phenotype in the absence of IL10. Whereas Treg cells generated in the absence of IL10 remain competent to sustain allogeneic pregnancy under steady-state conditions, in the event of inflammatory challenge their compromised stability would be a factor in the uNK cell activation and shift to Th1 immunity that causes fetal loss. These findings are relevant to understanding the role of IL10 in the immune response to pregnancy and may ultimately contribute to elucidating the pathology of preeclampsia and related complications of human pregnancy, where a less robust Treg cell response [23] and altered regulation of placental IL10 [68] are both implicated in the underlying inflammatory etiology.
